[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Introduction

The role of the b-HCG/LH/LH-R system in breast cancer is conflicting. Whereas some reports suggest a protective effect of b-HCG on breast epithelium, vitro studies implicate a role of b-HCG/LH-R in the development and growth of breast tumors.

Material and methods

In order to further investigate a possible involvement of b-HCG/LH-R in breast carcinogenesis, immunofluorescence analyses of b-HCG/LH-R expression was performed on 70 preinvasive and adjacent invasive breast cancer specimen using tissue microarrays (TMAs).

Results

In 37 preinvasive samples available for further analysis, b-HCG/LH-R was found in 8/37 samples (21.6%; weak, intermediate and strong staining in 4/37 (10.8%), 2/37 (5.4%) and 2/37 (5.4%). In contrast, b-HCG/LH-R expression was observed in 19/27 (70.4%) adjacent invasive specimen with weak, moderate and strong immunostaining in 10/27 (37.0%), 6/27 (22.2%) and 3/27 (11.1%), respectively. This was statistically significant when compared to preinvasive components (= 0.001, Chi Square Test).

Conclusions

Based on the observation that b-HCG/LH-R was found to be selectively upregulated in invasive tumor components, we suggest that under certain circumstances, sensitivity of ductal cells to hormones that target b-HCG/LH-R could favour mammary carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Bocker W, Decker T, Ruhnke M, Schneider W (1997) Ductal hyperplasia and ductal carcinoma in situ. Definition–classification–differential diagnosis. Pathologe 18:3–18. doi:10.1007/s002920050191

    Article  PubMed  CAS  Google Scholar 

  • Dufau ML (1998) The luteinizing hormone receptor. Annu Rev Physiol 60:461–496. doi:10.1146/annurev.physiol.60.1.461

    Article  PubMed  CAS  Google Scholar 

  • Han SW, Lei ZM, Rao CV (1996) Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin in mucosal cells from human fallopian tubes. Endocrinology 137:2929–2937. doi:10.1210/en.137.7.2929

    Article  PubMed  CAS  Google Scholar 

  • Hudelist G, Huber A, Knoefler M, et al (2008) Human chorionic gonadotropin/luteinizing hormone receptor (HCG/LH-R) expression in eutopic endometrium and endometriotic implants: evidence for HCG sensitivity of endometriosis. Reprod Sci 15(6):543–551

    Google Scholar 

  • Kuorelahti A, Rulli S, Huhtaniemi I, Poutanen M (2007) Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Endocrinology 148:3694–3703. doi:10.1210/en.2007-0249

    Article  PubMed  CAS  Google Scholar 

  • Lei ZM, Reshef E, Rao V (1992) The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab 75:651–659. doi:10.1210/jc.75.2.651

    Article  PubMed  CAS  Google Scholar 

  • Lei ZM, Toth P, Rao CV, Pridham D (1993a) Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 77:863–872. doi:10.1210/jc.77.3.863

    Article  PubMed  CAS  Google Scholar 

  • Lei ZM, Rao CV, Lincoln SR, Ackermann DM (1993b) Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis. J Clin Endocrinol Metab 76:763–768. doi:10.1210/jc.76.3.763

    Article  PubMed  CAS  Google Scholar 

  • Licht P, Russu V, Lehmeyer S, Wildt L (2001) Molecular aspects of direct LH/hCG effects on human endometrium—lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol 1:10–19

    PubMed  CAS  Google Scholar 

  • Licht P, von Wolff M, Berkholz A, Wildt L (2003) Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril 79(Suppl 1):718–723. doi:10.1016/S0015-0282(02)04822-7

    Article  PubMed  Google Scholar 

  • Lin J, Lei ZM, Lojun S, Rao CV, Satyaswaroop PG, Day TG (1994) Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 79:1483–1491. doi:10.1210/jc.79.5.1483

    Article  PubMed  CAS  Google Scholar 

  • Lojun S, Bao S, Lei ZM, Rao CV (1997) Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 57:1202–1210. doi:10.1095/biolreprod57.5.1202

    Article  PubMed  CAS  Google Scholar 

  • Mann RJ, Keri RA, Nilson JH (2003) Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog Horm Res 58:343–375. doi:10.1210/rp.58.1.343

    Article  PubMed  CAS  Google Scholar 

  • Minegishi T, Tano M, Abe Y, Nakamura K, Ibuki Y, Miyamoto K (1997) Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary. Mol Hum Reprod 3:101–107. doi:10.1093/molehr/3.2.101

    Article  PubMed  CAS  Google Scholar 

  • Piersma D, Berns EM, Verhoef-Post M et al (2006) A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J Clin Endocrinol Metab 91:1470–1476. doi:10.1210/jc.2005-2156

    Article  PubMed  CAS  Google Scholar 

  • Popnikolov N, Yang J, Liu A, Guzman R, Nandi S (2001) Reconstituted normal human breast in nude mice: effect of host pregnancy environment and human chorionic gonadotropin on proliferation. J Endocrinol 168:487–496. doi:10.1677/joe.0.1680487

    Article  PubMed  CAS  Google Scholar 

  • Rao Ch V, Li X, Manna SK, Lei ZM, Aggarwal BB (2004) Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J Biol Chem 279:25503–25510. doi:10.1074/jbc.M400683200

    Article  PubMed  CAS  Google Scholar 

  • Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

    PubMed  CAS  Google Scholar 

  • Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I (2002) Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143:4084–4095. doi:10.1210/en.2002-220490

    Article  PubMed  CAS  Google Scholar 

  • Shemesh M, Mizrachi D, Gurevich M et al (2001) Expression of functional luteinizing hormone (LH) receptor and its messenger ribonucleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in vivo. Reprod Biol 1:13–32

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Barbara Weidinger and Martha Weinhaeusl for technical assistance with the immunohistochemical procedures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian F. Singer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hudelist, G., Wuelfing, P., Czerwenka, K. et al. Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?. J Cancer Res Clin Oncol 135, 191–195 (2009). https://doi.org/10.1007/s00432-008-0458-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-008-0458-3

Keywords

Navigation